Two groundbreaking discoveries by UC San Francisco scientists have unlocked new insights into the intricate workings of the brain and the immune system, potentially revolutionizing our approach to treating neurological disorders and cancer. These findings, made by Daniele Canzio and Balyn Zaro, two esteemed researchers, could pave the way for innovative therapies and a deeper understanding of complex biological processes.
Unraveling the Origami-like DNA in Neurodevelopment
Canzio's research delves into the fascinating world of DNA folding, akin to origami, and its impact on brain development. Neurons, the brain's cellular messengers, extend branches to specific areas, ensuring efficient communication without redundancy. Each neuron possesses a unique 'barcode' that distinguishes it from others, despite all neurons sharing the same genetic instructions. This raises the intriguing question: How can billions of barcodes be generated when every cell has identical genetic information?
Canzio's team discovered that the DNA housing these barcodes lacks a fixed shape, folding like origami in different ways within various cells. This folding mechanism acts as a key, controlling DNA-level interactions and generating diverse barcoding identities. The process is dynamic, constantly occurring, breaking, and reforming throughout a neuron's lifespan.
The implications of this finding are profound. Understanding the intricacies of DNA folding could be the key to preventing and treating neurodiseases. By deciphering the errors in neurological disorders, we might one day be able to rewire faulty connections, potentially rewriting neuron identities to restore lost functions.
The Macrophage's Dilemma: Eating or Being Eaten
Zaro's research focuses on macrophages, a type of white blood cell, and their complex relationship with cancer cells. Macrophages play a crucial role in the immune system, acting as bouncers and cleanup crews. They decide who enters the body, remove pathogens or damaged cells, and call for backup when needed. However, in cancer, this process becomes dysregulated.
Zaro's team uncovered a surprising revelation: macrophages steal proteins from cancer cells, placing them on their surface during phagocytosis. This theft reprogrammes macrophages, pushing them towards behaviors that promote tumor growth and hinder their ability to clean up. The development of a new mass spectrometry method by Zaro's lab has revealed cancer proteins on macrophages' surfaces, a significant breakthrough.
The team is now working on a drug targeting these cells, aiming to selectively deliver drugs to macrophages with specific cancer proteins. By understanding and manipulating the macrophages' behavior, we might be able to develop more effective cancer therapies.
Pathogens' Sneaky Strategies
Zaro's research also sheds light on pathogens' ability to hijack the 'don't eat me' pathways used by healthy cells. This challenges the prevailing view that pathogens rely on distinct mechanisms to evade the immune system. By using mass spectrometry, Zaro's lab discovered that pathogens employ 'don't eat me' signals typically used by healthy cells to avoid being consumed by macrophages.
The ultimate goal is to create an antibody that can conceal the 'don't eat me' signal, allowing macrophages to clear pathogens effectively. This approach could potentially lead to new strategies for treating infectious diseases.
These breakthroughs, made possible by the unique approaches of Canzio and Zaro, have been recognized by the prestigious Bowes Biomedical Investigator Award. Their contributions not only advance scientific knowledge but also inspire further exploration and innovation in the fields of neuroscience and cancer research.
